[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CZ20011764A3 - Agent interacting with potassium channel and use thereof - Google Patents

Agent interacting with potassium channel and use thereof

Info

Publication number
CZ20011764A3
CZ20011764A3 CZ20011764A CZ20011764A CZ20011764A3 CZ 20011764 A3 CZ20011764 A3 CZ 20011764A3 CZ 20011764 A CZ20011764 A CZ 20011764A CZ 20011764 A CZ20011764 A CZ 20011764A CZ 20011764 A3 CZ20011764 A3 CZ 20011764A3
Authority
CZ
Czechia
Prior art keywords
potassium channel
agent interacting
interacting
agent
potassium
Prior art date
Application number
CZ20011764A
Other languages
Czech (cs)
Inventor
Kenneth Rhodes
Maria Betty
Huai-Ping Ling
Wenquian An
Original Assignee
Millennium Pharmaceuticals, Inc.
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/298,731 external-priority patent/US6369197B1/en
Priority claimed from US09/350,874 external-priority patent/US20020019020A1/en
Priority claimed from US09/400,492 external-priority patent/US7115381B1/en
Priority claimed from US09/399,913 external-priority patent/US6361971B1/en
Application filed by Millennium Pharmaceuticals, Inc., American Home Products Corporation filed Critical Millennium Pharmaceuticals, Inc.
Publication of CZ20011764A3 publication Critical patent/CZ20011764A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ20011764A 1998-11-20 1999-11-19 Agent interacting with potassium channel and use thereof CZ20011764A3 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US10933398P 1998-11-20 1998-11-20
US11003398P 1998-11-25 1998-11-25
US11027798P 1998-11-30 1998-11-30
US09/298,731 US6369197B1 (en) 1998-11-20 1999-04-23 Potassium channel interactors and uses therefor
US09/350,874 US20020019020A1 (en) 1998-11-20 1999-07-09 Methods for treating cardiovascular disorders
US09/350,614 US6689581B1 (en) 1998-11-20 1999-07-09 Potassium channel interactors and uses therefor
US09/400,492 US7115381B1 (en) 1998-11-20 1999-09-21 Methods for treating cardiovascular disorders
US09/399,913 US6361971B1 (en) 1998-11-20 1999-09-21 Nucleic acid molecules encoding potassium channel interactors and uses therefor

Publications (1)

Publication Number Publication Date
CZ20011764A3 true CZ20011764A3 (en) 2002-01-16

Family

ID=27574798

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011764A CZ20011764A3 (en) 1998-11-20 1999-11-19 Agent interacting with potassium channel and use thereof

Country Status (12)

Country Link
EP (1) EP1131349A2 (en)
JP (1) JP2002530104A (en)
CN (1) CN1346368A (en)
AU (1) AU775713B2 (en)
BR (1) BR9915513A (en)
CA (1) CA2351365A1 (en)
CZ (1) CZ20011764A3 (en)
IL (1) IL143148A0 (en)
MX (1) MXPA01004903A (en)
NO (1) NO20012471L (en)
NZ (1) NZ512332A (en)
WO (1) WO2000031133A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
EA200300420A1 (en) * 2000-09-27 2004-04-29 Милленниум Фамэсьютикэлс, Инк. Isolated nucleic acid molecules, isolated polypeptides AND METHOD FOR PRODUCTION THEREOF, METHOD FOR DETECTING THEM present in the sample (VARIANTS) host cell (VARIANTS) antibody kit (OPTIONS), a method of modulating activity of a polypeptide, IDENTIFICATION METHOD (VARIANTS) AND APPLICATION OF COMPOUNDS METHOD OF IDENTIFICATION OF THE SUBJECT (OPTIONS) AND METHOD OF TREATING THE SUBJECT WITH DAMAGE ASSOCIATED WITH POTASSIUM CHANNELS (OPTIONS)
AU2009312751B8 (en) * 2008-11-06 2015-04-09 Basf Se A screening assay for insecticides
GB201906482D0 (en) * 2019-05-08 2019-06-19 Evox Therapeutics Ltd Exosome comprising stabilized RNA therapeutics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016185A2 (en) * 1996-10-17 1998-04-23 Nps Pharmaceuticals, Inc. Potassium channel blocking compounds and their use
US6117989A (en) * 1998-03-26 2000-09-12 Incyte Pharmaceuticals, Inc. Human calcium-binding proteins

Also Published As

Publication number Publication date
WO2000031133A2 (en) 2000-06-02
NO20012471D0 (en) 2001-05-18
JP2002530104A (en) 2002-09-17
IL143148A0 (en) 2002-04-21
NZ512332A (en) 2004-02-27
NO20012471L (en) 2001-07-18
MXPA01004903A (en) 2003-03-10
WO2000031133A3 (en) 2000-10-05
CA2351365A1 (en) 2000-06-02
EP1131349A2 (en) 2001-09-12
CN1346368A (en) 2002-04-24
BR9915513A (en) 2002-02-05
AU1479700A (en) 2000-06-13
AU775713B2 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
GB9812413D0 (en) Compound and its use
IL183948A (en) Peg-urate oxidase conjugates and use thereof
HUP0104270A3 (en) Herbicidal composition and use thereof
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB9813271D0 (en) Composition and use
ZA200101933B (en) Novel composition and use
GB9817235D0 (en) Compound,composition and use
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
EP1056455A4 (en) Epimorphian compound and its use
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
GB9817236D0 (en) Compound,composition and use
GB9803232D0 (en) Compound composition and use
CZ20011764A3 (en) Agent interacting with potassium channel and use thereof
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
GB0100361D0 (en) Compound, composition and use
SG80037A1 (en) Potassium channel drugs and their uses
GB9805172D0 (en) Composition and use
GB9826830D0 (en) Potassium channel activators and their use
GB9911606D0 (en) Composition and use
EP1077705A4 (en) Potassium channel agonists
EP1066051A4 (en) Sciellin and uses thereof
PL324932A1 (en) Mould-killing agent
HK1046914A1 (en) Potassium channel interactors and uses therefor